ERCC2 helps cells repair DNA damage, especially damage from ultraviolet light, and it also supports normal gene activity. This gene helps your body protect skin and other tissues from everyday wear on DNA. If the ERCC2 gene does not work properly, damage can build up and may lead to strong sun sensitivity, a higher chance of skin cancer, or rare inherited conditions that affect growth, nerves, hair, or the eyes. ERCC2 is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do the work. Others mainly control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
ERCC2Gene function
What if the gene works
The ERCC2 gene helps cells repair damaged DNA, especially damage caused by ultraviolet light. It also helps cells read genetic instructions needed to make proteins and keep tissues working normally.
Risk
What if the gene does not work
Variants in the ERCC2 gene can weaken DNA repair. Milder to more severe variants may lead to sun sensitivity and a much higher chance of skin cancers, or to conditions with brittle hair, short stature, and developmental differences.
Treatment
What does that mean for your treatment
No ERCC2-specific treatment or management approach is currently established. Care is guided by the person’s condition and symptoms rather than a drug chosen for the ERCC2 gene itself. In cancer care, ERCC2 variants are being studied as biomarkers that may help predict response to platinum chemotherapy, especially in bladder cancer.
Conditions associated with ERCC2
Gene function
What if the gene works
Your cells constantly open, read, and repair DNA. The ERCC2 gene helps with these routine jobs by making a protein that opens small sections of DNA at the right time. This supports both DNA repair and normal gene activity across the body.
The ERCC2 gene helps make a protein that acts as a helicase (an enzyme that separates the two DNA strands). This gives your cells access to the stretch of DNA they need to work on.
This protein helps your cells open damaged DNA so the injured section can be removed and replaced. That is a key part of how the ERCC2 gene helps repair DNA damage from sunlight and some chemical exposures.
ERCC2 also supports the first steps of gene reading, when cells copy DNA instructions into RNA messages. By helping open DNA at active genes, it supports everyday protein production and routine cell function.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. Variants are common and help shape normal human diversity, such as differences in appearance, metabolism, or the body's response to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene's function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ERCC2 gene can change how the protein folds, how stable it is, or how well it works with other DNA repair proteins, which helps explain how ERCC2 gene variants affect protein function. Some variants only partly reduce activity, while more severe variants can sharply impair the protein or block key interactions. That functional range often shapes which ERCC2-related condition appears and, in some people, how early or how strongly features show up.
How variants are linked to conditions
Pathogenic variants in both copies of the ERCC2 gene can cause xeroderma pigmentosum, especially group D, which is linked to marked sun sensitivity and a much higher chance of skin cancer. Other ERCC2 variants can cause trichothiodystrophy, which often affects hair, skin, growth, and development. Some variants are linked to rarer overlapping childhood conditions. Research on ERCC2 gene variants and cancer risk in common cancers has been mixed, so these findings do not establish a diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with ERCC2-related xeroderma pigmentosum, ultraviolet light from the sun and tanning beds can greatly raise the chance of skin damage and skin cancer. The genetic change itself is the main driver, so sun protection lowers harm and complications rather than removing the underlying risk.
Inheritance of ERCC2 variants
ERCC2-related conditions are usually inherited in an autosomal recessive pattern. This means a child inherits two disease-causing ERCC2 gene variants, one from each parent, while parents who carry one variant are usually unaffected carriers. When both parents carry an ERCC2 gene variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with no familial variant. In practical terms, ERCC2 inheritance often appears unexpectedly in a family because carrier parents may have no symptoms themselves.
What does my ERCC2 result mean for my family?
For ERCC2, family implications are usually discussed in the setting of recessive inherited conditions. This often means parents may be healthy carriers, brothers and sisters could also be carriers or, less often, could have the condition, and other relatives on both sides of the family may carry the same gene change. The exact impact for family members depends on the specific ERCC2-related condition linked to the result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change, genetic testing for variants in the ERCC2 gene uses DNA from blood, saliva, or a cheek swab. A lab reads the gene’s sequence and compares it with the usual version to identify variants that may help clarify a diagnosis or carrier status.
When should I consider getting a genetic test?
Consider ERCC2 testing if you or your child has signs of a rare inherited condition linked to this gene, such as extreme sun sensitivity, repeated early skin cancers, brittle hair, or developmental problems. Testing can also make sense when these problems run in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the kind of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, does very little for another, or causes more side effects in someone else. Part of the difference comes from inherited changes that influence how the body breaks down, transports, or responds to a drug. These differences are common and can shape both how well a medicine works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect a person’s response to medications. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can help support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the ERCC2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general concerns about side effects or how well a treatment is working are best discussed with your doctor. ERCC2 has been studied in cancer care, especially for how some gene changes may affect response to platinum chemotherapy such as cisplatin, but this is not yet standard guidance for routine prescribing.
History
ERCC2 entered medical genetics through research on rare inherited conditions marked by extreme sensitivity to sunlight and early skin cancer, especially xeroderma pigmentosum. In the 1980s and 1990s, researchers showed that cells from some affected families could not properly repair DNA damage caused by ultraviolet light. From these first observations, research expanded steadily. Scientists then identified the ERCC2 gene, also known historically as XPD, and linked different variants to xeroderma pigmentosum, trichothiodystrophy, and Cockayne syndrome features in some people. This work became an important part of the broader story of DNA repair research and helped connect inherited skin cancer risk with specific repair pathways. Over time, ERCC2 also gained attention in cancer research because changes in this gene were found in some tumors.